← FDA Drug Approvals (Drugs@FDA)
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-06-03
Drug application
- FDA Application #
ANDA206894- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
- Generic name
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- Active ingredients
- EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CIPLA
- Manufacturer
- Cipla USA Inc.
- First approval
- 2019-06-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown